Live feed
·
INSIDERFiling
Sarepta Therapeutics Inc. logo

President, R&D and Tech Ops Rodino-Klapac Louise converted options into 8,125 shares and covered exercise/tax liability with 4,485 shares, increasing direct ownership by 2% to 227,670 units (SEC Form 4)